Management Forum Logo

Presented by
Management Forum

Effective Technology Transfer Training Course

The ‘how to’ of technology transfer across the product lifecycle

★★★★★ "The training course exceeded my expectations.The course was well structured ,with a perfect balance ... more (21)"

3-4 February 2025
+ 2-3 June 2025, 6-7 October 2025 »

from £1299

Need help?  Enrol/reserve

Course overview

Technology transfer (TT) is an increasingly important part of the pharmaceutical industry, with companies expanding the use of third parties for both development and manufacture.

There are few formal guidelines around this subject, but regulators expect companies to get it right for both internal and external transfers. Poorly run transfers can be costly and impact product quality, whereas well-run transfers bring business benefits and assure product quality.

Attending this highly practical course will give participants the tools to help guide them through achieving successful transfers. It is applicable to those making transfers from development to commercial, from commercial to commercial, for scale-up, analytical methods or for ‘virtual’ companies.

The programme covers pharmaceutical products, including ATMPs and combination products, but does not include medical devices.

Benefits of attending:

  • Understand that technology transfer (TT) is part of the product life cycle, supported by the pharmaceutical quality system
  • Know where TT is covered in ICH, FDA, EU, WHO and PIC/S guidelines
  • Learn the key steps for successful transfers
  • Know how to engage sending and receiving units (SU and RU) for TT
  • Understand how product and process understanding enables TT
  • Apply tools such as quality risk management and clarify risks involved in TT
  • Understand how change should be handled, eg facility and equipment differences between SU and RU; scale-up
  • Learn how analytical method transfers are an integral part of TT
  • Recognise how TT impacts a wide range of companies from innovative to generic, including development, manufacturing, major corporations and ‘virtual’ companies
  • Realise how significant business benefits emerge from successful TT
  • Understand TT for pharmaceutical products, including combination products and ATMPs

This course is part of our GxP training (Good x Practice) course collection, which features a variety of topic areas to ensure you comply with the most recent quality guidelines. For more information on the latest EU GMP regulations, see our GMP training course covering the Annex 1.

Who should attend

This seminar will be of particular interest to all those from the pharmaceutical industry working in:

  • Development
  • Manufacturing
  • Engineering
  • Quality

The following personnel from the pharmaceutical and biopharmaceutical industries will also find it beneficial:

  • Pharmacists
  • Scientists
  • Engineers
  • Quality assurance professionals
  • Quality control managers
  • Late-stage product and process development engineers, scientists, pharmacists
  • Technology scale-up and transfer managers
  • Validation and qualification specialists
  • Risk management specialists
  • Operation managers

Enrol/reserve

This course will cover:

Regulatory guidance and business drivers for TT

ICH Q10

Exercise 1 - What Makes a Successful TT?

Industry guidance for sending and receiving units (SU and RU)

Knowledge

  • What do SU and RU need?

Exercise 2: Knowledge


Science and risk-based approaches - part one

Science and risk-based approaches - part two

Equipment and utilities

Exercise 3: Equipment at SU and RU


Quality risk management

Project management steps for TT - part one

Exercise 4 - Case Study - Fishbone for TT


Project management steps for TT - part two

Exercise 5: Case Study - Organising TT


Validation and qualification

Exercise 6: SU And RU


Analytical method transfer - part one

Analytical method transfer - part two

Enabling successful TT – ‘softer’ issues

Enrol/reserve

Bruce Davis
Bruce Davis Ltd

Bruce Davis runs his own training/consultancy company for science and risk based approaches to Engineering and Process Validation (PV), Quality by Design (QbD), Technology Transfer (TT), Quality Risk Management and other related topics. He has run many training events for companies both in the UK and internationally. He is past Chair of ISPE International Board of Directors. He led, co-lead or contributed to a number of their guidances for PV, QbD & TT and most recently has co-written one chapter on TT for ATMPs (i.e personalised medicines) . He is a professional engineer with many years’ experience in the pharmaceutical industry and a wide international knowledge. He previously worked at AstraZeneca, where his responsibilities included managing international engineering and leading changes to qualification practices. He is an established trainer and likes to engage with participants, to try to ensure the training experience is related to their particular requirements, and to bring in the importance of science and risk based thinking.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

3-4 February 2025

Live online

09:00-16:30 UK (London) (UTC+00)
10:00-17:30 Paris (UTC+01)
04:00-11:30 New York (UTC-05)
Course code 14446

  • GBP 1,299 1,499
  • EUR 1,819 2,099
  • USD 2,087 2,399

Until 30 Dec

View basket 

 
Not ready to book yet?

for 7 days, no obligation

2-3 June 2025

Classroom
Rembrandt Hotel
London

09:00-17:00 UK (London)
Timings may be different for each day
Course code 14975
Optional £290/€404/$462 per night

  • GBP 1,499 1,699
  • EUR 2,099 2,379
  • USD 2,407 2,719

Until 28 Apr

  • 2 days classroom-based training
  • Optional accommodation - 2 nights including breakfast, checking in the day before the course
  • Meet presenters and fellow attendees in person
  • Lunch and refreshments provided
  • Download documentation and certification of completion
  • Fair transfer and cancellation policy

View basket 

 
Not ready to book yet?

for 7 days, no obligation

6-7 October 2025

Live online

09:00-16:30 UK (London) (UTC+01)
10:00-17:30 Paris (UTC+02)
04:00-11:30 New York (UTC-04)
Course code 14622

  • GBP 1,299 1,499
  • EUR 1,819 2,099
  • USD 2,087 2,399

Until 01 Sep

View basket 

 
Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

Reviews of IPI's Effective Technology Transfer training course


The training course exceeded my expectations.The course was well structured ,with a perfect balance of theory and practical applications. The speaker was knowledgeable, approachable, and provided clear detailed explanations.

Oct 7 2024

Maria Galanou
Quality Affairs for New Products Expert, Pharmathen

Jul 16 2024

Bruce had an outstanding performance as speaker! I truly recommend everyone to have the chance to exchange knowledge with Bruce.

David Miguel Soares Dias
Regulatory Affairs Team Lead, Generis Farmacêutica S.A.

Jan 23 2024

Very good

Jeļena Gurko
Leading Industrial Pharmacist, JSC

Oct 7 2024

I am very satisfied with the course. I came away with what I came for. [Speaker was] amazing. A person on the ground [with] very well presented material interspersed with occasional jokes.

Petra Hlouzkova
Technical Services Supervisor, Novavax

Jul 16 2024

Yes, the webinar helped me understand the whole tech transfer from start to finish. Bruce's key elements and points were brilliant. Further, these points can easily be practised at any stage of the project.

Dhaval Pandeji
Senior Regulatory Affairs Officer, Neon Healthacare Limited

Jul 16 2024

Mr. Davis was very helpful during the presentation, the explanations were very clear and understandable and he was always willing to answer our questions. The slides were very organized and the presentation was very clear

Paraskevi Vitoratou
Pharmaceutical and Manufacturing Technology Scientist, PharmaPath S.A.

Jul 16 2024

Mr. Davis was very helpful during the presentation, the explanations were very clear and understandable and he was always willing to answer our questions. The content was exactly what I was looking for and helped me gain more knowledge regarding my job.

Paraskevi Vitoratou
Pharmaceutical and Manufacturing Technology Scientist, PharmaPath S.A.

Jul 16 2024

Bruce has been an excellent speaker to help understand the key steps for a successful tech transfer. His expertise in the pharmaceutical industry and clear explanations made the learning experience very valuable. The continuous interaction between Bruce and the participants was excellent to dynamize the course and to expand knowledge within different industry areas.

Robert Bergé Sarroca
Process Development Scientist, Instituto Grifols S.A.

Jan 23 2024

Bruce seemed very knowledgeable thanks to all his years working within the industry.

Andrés Bueno Venegas
Scientific consultant, Emendo R&D

Apr 19 2023

The presentations were in a clear, understandable, well structured form

István Szabó
Plant manager, Gedeon Richter

Oct 11 2022

The explanations of the proposed topics were very acceptable and the relation between the theoretical and practical parts was very outstanding.

Álvaro García Ramos
Head of R&D, Grupo Juste (Justesa Imagen SAU)

Apr 6 2022

It was a very useful training that fulfil my necessities about the Industry standards for the Technology transfers... Bruce is very knowledgeable and he was continuously asking the participants to provide feedback and their own experiences.

Sergio Molina Zaragoza
Vice President Research and Development, Grifols Biologicals LLC

Jan 11 2022

The course contains a lot of brilliant insights into the issues with tech transfer process and how to effectively manage these issues with adequate planning, controls and communication.

Emir Bouleghlimat
Purolite Ltd

Jan 11 2022

A very well rounded course that formalised and expanded on a lot of knowledge/understanding that we were in the process of developing ourselves. The course contains a lot of brilliant insights into the issues with tech transfer process and how to effectively manage these issues with adequate planning, controls and communication. Overall I was very impressed with the course and Bruce, and would recommend anyone involved in a process where methods/tech are being transferred to sign up to this course.

Emir Bouleghlimat
Purolite Ltd

Jan 11 2022

Everything set in the agenda was covered. No issues with presentation, if any help required we were able to privately message Natalia. The speed at which Bruce spoke through the documents was good and I was happy there was multiple opportunities to make comments, discuss topic and conduct exercises on what we just learnt.

Amaira Umer
QA Officer, Purolite Ltd

Jan 11 2022

Bruce was very polite and interactive. The use of real-life examples, I thought was great to help apply and understand certain points.

Liam Evans
Purolite Ltd

Oct 5 2021

He [Bruce Davis] was very friendly, professional and thoughtful. He encouraged all the trainees to participate in the exercises in a very positive & constructive way.

Grace Jung
Senior Scientist, Design Transfer, Speedx Pty Ltd

Oct 5 2021

[The speaker] was very friendly, professional and thoughtful. He encouraged all the trainees to participate in the exercises in a very positive & constructive way.

Grace Jung
Senior Scientist, Design Transfer, Speedx Pty Ltd

Nov 19 2019

The course was absolutely great and to get helpful advice from the experienced speaker was fantastic.

Ulrike Ratz
CMC Manager, Cheplapharm Arzneimittel GmbH

May 21 2019

Good all round course covering all aspects of Tech Transfer.

Frances Morrissey
Product Specialist - Global Technical Management, Norgine Limited

May 21 2019

Really worthwhile course that I would recommend to my colleagues. I have several practical tools that will help me in my future technology transfers.

Laura Hearthward
Product Development Manager, Torbay Pharmaceuticals

United Kingdom

  • Arecor Ltd
  • Compass Pathways
  • Dechra Limited
  • Genethics Regulatory Services
  • Morningside Healthcare Limited
  • Mundipharma Research Ltd
  • Neon Healthacare Limited
  • Norgine Limited
  • Norgine Ltd
  • Purolite Ltd
  • Rentschler ATMP Ltd
  • Sekisui Diagnostics
  • Torbay Pharmaceuticals

Germany

  • Aristo Pharma GmbH
  • Bayer Consumer Care AG
  • BMS
  • Cheplapharm Arzneimittel GmbH
  • Fresenius Kabi Deutschland GmbH
  • Minaris Regenerative Medicine GmbH

Denmark

  • Emendo R&D
  • Fujifilm Diosynth Biotechnologies
  • Statens Serum Institut

Italy

  • Chiesi Farmaceutici S.p.a.
  • RECORDATI S.P.A.
  • Zambon SpA

Netherlands

  • Amgen
  • Kinesis Pharma
  • Sever Pharma Solutions

Norway

  • Fresenius Kabi Ltd
  • Fresenius Kabi Norway
  • Oslo universitetssykehus

Spain

  • Grupo Juste (Justesa Imagen SAU)
  • Instituto Grifols S.A
  • Instituto Grifols S.A.

Switzerland

  • Bazell Pharma AG
  • Celonic AG
  • Ichnos Sciences

Australia

  • Speedx Pty Ltd
  • SpeeDx Pty ltd.

Greece

  • PharmaPath S.A.
  • Pharmathen

Hungary

  • Gedeon Richter
  • Gedeon Richter Plc

Portugal

  • CIPAN,SA
  • Generis Farmacêutica S.A.

Austria

  • Boehringer Ingelheim Pharma Co.KG

Czech Republic

  • Novavax

Finland

  • FinVector Oy

Iceland

  • Oculis

India

  • Morningside Healthcare

Ireland

  • Avectas

Latvia

  • JSC

Sweden

  • Knightec AB

United States of America

  • Grifols Biologicals LLC

Enrol/reserve

Run Effective Technology Transfer Live online/Classroom for your team

2 days

Typical duration

Pricing from:

  • GBP 800
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online

 

We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra BEER
Training expert

Yesim Nurko

Yesim NURKO
Training expert

+44 (0)20 7749 4749

inhouse@ipi.academy